The company also granted the underwriters a 30-day option to purchase up to an additional 825,000 shares.
Price: 24.17, Change: , Percent Change:
|Insider Trends: 90-Day Buying Trend Prolonged with I...|
|Prevail Therapeutics Posts Wider-Than-Estimated Q3 Loss|
|Analyst Actions: Royal Bank of Canada Resume Coverag...|
|--Analyst Actions: Oppenheimer Lifts Fiserv's Price ...|
|Analyst Actions: Northcoast Research Downgrades Wrig...|